These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Singh S, Loke YK, Furberg CD. JAMA; 2008 Sep 24; 300(12):1439-50. PubMed ID: 18812535 [Abstract] [Full Text] [Related]
4. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial. Tashkin DP. Expert Rev Respir Med; 2010 Jun 24; 4(3):279-89. PubMed ID: 20524910 [Abstract] [Full Text] [Related]
5. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Tashkin DP. Curr Opin Pulm Med; 2010 Mar 24; 16(2):97-105. PubMed ID: 20019615 [Abstract] [Full Text] [Related]
7. A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD. Hilleman DE, Malesker MA, Morrow LE, Schuller D. Int J Chron Obstruct Pulmon Dis; 2009 Mar 24; 4():253-63. PubMed ID: 19657399 [Abstract] [Full Text] [Related]
9. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin DP, UPLIFT Study Investigators. Am J Respir Crit Care Med; 2009 Nov 15; 180(10):948-55. PubMed ID: 19729663 [Abstract] [Full Text] [Related]
10. Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence. Salpeter SR. Drugs; 2009 Oct 22; 69(15):2025-33. PubMed ID: 19791824 [Abstract] [Full Text] [Related]
11. The efficacy and safety of tiotropium in Chinese patients with stable chronic obstructive pulmonary disease: a meta-analysis. Wu Q, Li G, Lei WI, Zhou X. Respirology; 2009 Jul 22; 14(5):666-74. PubMed ID: 19402836 [Abstract] [Full Text] [Related]
12. Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD. Verhamme KM, Afonso A, Romio S, Stricker BC, Brusselle GG, Sturkenboom MC. Eur Respir J; 2013 Sep 22; 42(3):606-15. PubMed ID: 23520322 [Abstract] [Full Text] [Related]
13. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease. Gershon AS, Wang L, To T, Luo J, Upshur RE. COPD; 2008 Aug 22; 5(4):229-34. PubMed ID: 18671148 [Abstract] [Full Text] [Related]